Asylia Diagnostics Company
Asylia Diagnostics - precision medicine data platform for immunotherapies
.jpeg)
Industry:
Early drug development, United States
Headquarters:
Delaware City, Delaware, United States
Founded Date:
2019-08-22
Employees Number:
1-10
Funding Status:
Seed
Investors Number:
2
Total Funding:
1100000
Estimated Revenue:
Less than $1M
Last Funding Date:
2020-03-02
Last Funding Type:
Pre-Seed
Register and Claim Ownership